Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009–2022 Ryosuke KuribayashiAyuki NakanoFutaba Honda Leading Article 25 May 2023 Pages: 443 - 451
Base Editing and Prime Editing: Potential Therapeutic Options for Rare and Common Diseases Lauren C. TestaKiran Musunuru Review Article 14 June 2023 Pages: 453 - 462
Lupus Nephritis: New and Emerging Biologic and Targeted Therapies Ajinath KaleMaciej LechAnil Bhanudas Gaikwad Review Article 24 April 2023 Pages: 463 - 475
The Role of Biologics in the Treatment of Chronic Rhinosinusitis Nora HaloobKaterina KaramaliClaire Hopkins Review Article 15 June 2023 Pages: 477 - 487
Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma Saïf Eddine ZaidiEliese MoelkerMustafa Khasraw Review Article 31 May 2023 Pages: 489 - 503
Antibody–Drug Conjugates in the Treatment of Urothelial Cancer Avani M. SinghJose A. Guevara-PatinoRohit K. Jain Review Article 31 May 2023 Pages: 505 - 520
CAR-T Cells and the Kidney: Insights from the WHO Safety Database Alexandre O. GérardDiane MerinoMilou-Daniel Drici Original Research Article Open access 11 May 2023 Pages: 521 - 530
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans Tianzhou YuShihan JinJakub P. Hlávka Original Research Article Open access 01 April 2023 Pages: 531 - 540
Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor Jette A. van LintNaomi T. JessurunBart J. F. van den Bemt Original Research Article Open access 03 April 2023 Pages: 541 - 550
Assessing the Interchangeability of AVT02 and Humira® in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study Steven R. FeldmanRichard KayFausto Berti Original Research Article Open access 19 May 2023 Pages: 551 - 567
Characterization for the Similarity Assessment between Proposed Biosimilar SB12 and Eculizumab Reference Product Using a State-of-the-Art Analytical Method Hyunsoo KimEunkyoung HongTaekyung Yoo Original Research Article Open access 15 April 2023 Pages: 569 - 581